NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) |
1 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Jun. 29, 2026 |
Oct. 22, 2025 |
Oct. 16, 2025 |
Jun. 12, 2025 |
Jun. 21, 2021 |
Jul. 31, 2018 |
Mar. 10, 2017 |
Oct. 31, 2025 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Number of shares issued | 26,905,969 | |||||||||
| Reverse stock split | 1 for 1,500 | 1-for-1,500 | ||||||||
| Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | |||||||
| Preferred stock, par value | $ 0.001 | $ 0.001 | ||||||||
| Common stock, shares outstanding | 994,379 | 944,935 | ||||||||
| Cash equivalents | $ 0 | $ 0 | ||||||||
| Uncertain tax positions | $ 0 | |||||||||
| Licensing Agreement [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Licensing fee | $ 5,000 | |||||||||
| Milestone payments | 75,000 | |||||||||
| Milestone payments on initiation of clinical trial | 200,000 | |||||||||
| Milestone payments on first regulatory approval | $ 300,000 | |||||||||
| Royalty payment description | The royalties for dietary supplement sales are 2.25% for net sales between $1-$10 million, 2.5% for net sales between $10 million and $50 million, and 3% for net sales between $50 million and $100 million. Royalty payments for dietary products are capped at $100 million in net sales. Royalties for drug products are 1% for net sales between $1 and $100 million, 1.5% for net sales between $100 million and $500 million, and 2% for net sales greater than $500 million. | |||||||||
| Sublicense royalty percentage | 12.00% | |||||||||
| Licensing Agreement [Member] | Minimum [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Increase in licensing fee | $ 5,000 | |||||||||
| Licensing Agreement [Member] | Maximum [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Increase in licensing fee | $ 30,000 | |||||||||
| Series A Convertible Preferred Stock [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Preferred stock, shares issued | 7,628,655 | 9,111,998 | ||||||||
| Series B Preferred Stock [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Common stock, voting rights | On June 29, 2026, the Controlling Shareholder entered into the Share Purchase. Through the Controlling Shareholder’s ownership of all outstanding shares of the Company’s Series A Preferred Stock and Series B Preferred Stock, Trafalgar Asset Management, LLC possesses approximately 96.62% of the aggregate voting power of the Company’s outstanding voting securities as of June 29, 2026, based upon 994,379 shares of Common Stock outstanding, each share of Series A Preferred Stock being entitled to 1.76 votes per share, and the outstanding shares of Series B Preferred Stock collectively being entitled to 51% of all votes entitled to be cast. | |||||||||
| Reverse stock split | 1-for-1,500 | |||||||||
| Series B Convertible Preferred Stock [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Number of shares issued | 100,000 | |||||||||
| Preferred stock, shares issued | 1,000 | 1,000 | 1,000 | 1,000 | ||||||
| Preferred stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||
| Green C Corporation [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Percentage of issued and outstanding shares acquired | 50.30% | |||||||||
| Green C Corporation [Member] | Former Share Holders [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Percentage of issued and outstanding shares acquired | 94.00% | |||||||||
| Green C Corporation [Member] | Class A Common Stock [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Percentage of issued and outstanding shares acquired | 100.00% | |||||||||
| Green C Corporation [Member] | Series A Convertible Preferred Stock [Member] | ||||||||||
| Property, Plant, and Equipment [Line Items] | ||||||||||
| Number of shares issued | 9,411,998 | |||||||||
| Common stock, voting rights | Each share of Series A Convertible Preferred Stock is convertible into 50 shares of common stock and is entitled to vote 50 votes per share on all matters as a class with holders of common stock |